
==== Front
Sci Rep
Sci Rep
Scientific Reports
2045-2322
Nature Publishing Group UK London

39223288
71383
10.1038/s41598-024-71383-6
Article
Association between alcohol consumption and incidence of type 2 diabetes in middle-aged Japanese from Panasonic cohort study 12
Takahashi Fuyuko 1
Okada Hiroshi conti@koto.kpu-m.ac.jp

1
Hashimoto Yoshitaka 12
Kurogi Kazushiro 3
Murata Hiroaki 4
Ito Masato 3
Fukui Michiaki 1
1 https://ror.org/028vxwa22 grid.272458.e 0000 0001 0667 4960 Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-Cho, Kawaramachi-Hirokoji, Kamigyo-Ku, Kyoto, 602-8566 Japan
2 https://ror.org/03ycmew18 grid.416591.e 0000 0004 0595 7741 Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, 5-55 Sotojima-Cho, Moriguchi, 570-8540 Japan
3 Department of Health Care Center, Panasonic Health Insurance Organization, 5-55 Sotojima-Cho, Moriguchi, 570-8540 Japan
4 https://ror.org/03ycmew18 grid.416591.e 0000 0004 0595 7741 Department of Orthopaedic Surgery, Matsushita Memorial Hospital, 5-55 Sotojima-Cho, Moriguchi, 570-8540 Japan
2 9 2024
2 9 2024
2024
14 2031522 1 2024
27 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
This retrospective cohort study aimed to investigate the association between alcohol consumption and the onset of type 2 diabetes in middle-aged Japanese individuals. Participants were aged 40 and above from Panasonic Corporation, Osaka, Japan’s medical health checkup program from 2008 to 2021. Alcohol consumption was calculated by converting the quantity consumed into daily ethanol consumption. We assessed the association between alcohol consumption and the onset of type 2 diabetes using Cox regression analysis. The total and median follow-up duration was 13 years and 7 (3–13) years (748,090 person-years). Among 102,802 participants, 7,510 participants (7.3%) developed type 2 diabetes during the study period. Alcohol consumption at the level of 0 < to < 22 g/day and 22 to < 39 g/day were negatively associated with developing type 2 diabetes compared to complete alcohol abstainers. Alcohol consumption at levels of 39 to < 66 g/day and at levels of ≥ 66 g/day were positively associated with developing type 2 diabetes in participants with BMI < 25 kg/m2. All levels of alcohol consumption were negatively associated with developing type 2 diabetes in participants with BMI ≥ 25 kg/m2. Moderate-to-heavy alcohol consumption were positively associated with developing type 2 diabetes for participants with BMI < 25 kg/m2, whereas alcohol intake was negatively associated with developing type 2 diabetes among participants with BMI ≥ 25 kg/m2.

Keywords

Type 2 diabetes
Obesity
Alcohol consumption
Subject terms

Metabolic disorders
Risk factors
Endocrine system and metabolic diseases
issue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

Globally, the prevalence of diabetes is rapidly increasing. The prevalence of diabetes in 20–79 years in 2021 was estimated to be 536.6 million people in the world, rising to 783.2 million in 20451. Japan is the country with the ninth largest population with diabetes in the world. Individuals with type 2 diabetes have a high risk of complications, including cardiovascular diseases and sarcopenia2,3. Therefore, it is important to prevent the development of type 2 diabetes. Improvement in dietary habits, including alcohol consumption and exercise, is crucial for preventing the onset of diabetes4–6.

Several meta-analyses have focused on Western populations regarding the association between alcohol consumption and the development of diabetes7–13. Alcohol consumption improves insulin sensitivity and reduces HbA1c levels7. Daily alcohol consumption < 24 g was negatively associated with developing type 2 diabetes compared with non-drinkers, whereas daily alcohol consumption > 24 g was not related to developing type 2 diabetes8. Daily alcohol consumption of 12–24 g/day was negatively related to developing type 2 diabetes13. The relative risk of type 2 diabetes was lowest, with a daily alcohol intake of 22 g in males and 24 g in females9. Daily alcohol consumption of less than 48 g10 or 63 g11 was negatively associated with developing type 2 diabetes. The negative association was observed to be less than 49 g in females12. In summary, light or moderate alcohol consumption may be negatively associated with the onset of type 2 diabetes in individuals from Western societies. However, previous studies focusing on Asian populations have reported varying results. One meta-analysis suggested that daily alcohol consumption > 57 g/day was positively associated with developing type 2 diabetes in Asian men14. Observational studies have reported the relationship between alcohol consumption and the onset of type 2 diabetes in Asian populations. Some reports have suggested that alcohol consumption is positively associated with developing type 2 diabetes15–19. Some studies have suggested that alcohol consumption is negatively associated with developing type 2 diabetes20–22. A report also suggested that alcohol consumption is not associated with the development of type 2 diabetes23. Other reports have suggested a U-shaped association between alcohol consumption and the onset of type 2 diabetes24,25. In summary, the relationship between alcohol consumption and onset of diabetes in Asians remains controversial. The discrepancies in these reports among Asians can be attributed to a lack of consideration of blood tests, small sample sizes, and short observation periods in individual studies. Moreover, the Asian population has a lower body mass index (BMI) and insulin resistance than the Western population. Additionally, the BMI of patients with diabetes is not remarkably greater than that of the general population in the Asian population, who tend to have reduced insulin secretion rather than insulin resistance26, suggesting that the relationship between alcohol consumption and the onset of diabetes might differ between these two populations. Therefore, in this study, we evaluated the association between alcohol consumption and the onset of type 2 diabetes in a large-scale, long-term cohort of Japanese individuals.

Results

In total, 102,802 participants were enrolled (Fig. 1). Table 1 displays the baseline characteristics of the research participants. The average age and BMI were 47.9 ± 5.8 years and 23.2 ± 3.3 kg/m2, respectively. The proportions of daily alcohol consumption were 35.1% for 0 g/day, 36.9% for 0 < to < 22 g/day, 17.7% for 22 to < 39 g/day, 8.7% for 39 to < 66 g/day, and 1.6% for ≥ 66 g/day. Table 2 displays type 2 diabetes incident cases and incidence rates by alcohol usage. The median follow-up duration was 7 (3–13) years (748,090 person-years). During the study period, 7,510 participants developed type 2 diabetes. The incidence rates of type 2 diabetes were 6.9% for daily alcohol consumption of 0 g/day, 6.8% for 0 < to < 22 g/day, 7.8% for 22 to < 39 g/day, 9.6% for 39 to < 66 g/day, and 9.2% for ≥ 66 g/day in whole participants. The adjusted hazard ratios (HRs) for incident type 2 diabetes are shown in Table 3. Multivariable analysis showed the HR of alcohol consumption at the level of 0 < to < 22 g/day (HR, 0.85; 95% CI, 0.81–0.90) and 22 to < 39 g/day (HR, 0.92; 95% CI, 0.86–0.99) were lower than those of 0 g/day. The HR of alcohol consumption at the level of 39 to < 66 g/day and ≥ 66 g/day were 0.99 (95% CI, 0.83–1.18) and 1.06 (95% CI, 0.90–1.25), respectively. The results of the subgroup analysis, examining the effects of BMI, FPG, and sex on the association between alcohol consumption levels and incidence of type 2 diabetes, are shown in Figs. 2, Supplementary Figs 1 and 2. There was an interaction effect (P for interaction < 0.0001) between alcohol consumption and BMI. In participants with BMI < 25 kg/m2, the HR of alcohol consumption levels of 39 to < 66 g/day and ≥ 66 g/day were higher than those of 0 g/day. On the other hand, the HR of alcohol consumption levels of 0 to < 22 g/day, 22 to < 39 g/day, 39 to < 66 g/day, and ≥ 66 g/day were lower than those of 0 g/day in individuals with BMI ≥ 25 kg/m2. We found no interaction effect between alcohol consumption and FPG category (P for interaction = 0.13) and sex (P for interaction = 0.42).Fig. 1 Flow diagram of participants’ registration.

Table 1 Characteristics of participants at baseline.

N	102,802	
Age (y)	47.9 (5.8)	
Male, n, (%)	79,464 (77.3)	
Body mass index (kg/m2)	23.2 (3.3)	
Systolic blood pressure (mmHg)	120.0 (15.0)	
Diastolic blood pressure (mmHg)	75.5 (11.1)	
Aspartate aminotransferase (IU/L)	22.5 (12.0)	
Alanine aminotransferase (IU/L)	24.5 (18.2)	
Low-density lipoprotein cholesterol (mg/dL)	126.5 (31.1)	
High-density lipoprotein cholesterol (mg/dL)	60.5 (15.6)	
Triglycerides (mg/dL)	115.8 (90.7)	
Fasting plasma glucose (mg/dL)	93.9 (9.4)	
Uric acid (mg/dL)	5.8 (1.4)	
Smoking (none/past/current), n, (%)	52,324/15,853/34,625 (50.9/15.4/33.7)	
Alcohol consumption

(none /0 < to < 22 /22 to < 39 /39 to < 66 / ≥ 66 g/day), n, (%)

	36,092/37,911/18,203/8,960/1,636

(35.1/36.9/17.7/8.7/1.6)

	
Physical exercise, n, (%)	18,361 (17.9)	
Data are presented as mean (standard deviation, or percentage) or absolute number.

Table 2 Incident cases and incident rate for type 2 diabetes according to alcohol consumption.

	0 g/day	0 < to < 22 g/day	22 to < 39 g/day	39 to < 66 g/day	 ≥ 66 g/day	Total	
Whole, n	36,092	37,911	18,203	8960	1636	10,2802	
Incident diabetes (%)	2,490 (6.9)	2,594 (6.8)	1,414 (7.8)	861 (9.6)	151 (9.2)	7,510 (7.3)	
BMI < 25 kg/m2, n	26,521	27,984	13,736	6509	1197	75,947	
Incident diabetes (%)	997 (3.8)	1220 (4.4)	811 (5.9)	489 (7.5)	93 (7.8)	3,610 (4.8)	
BMI ≥ 25 kg/m2, n	9571	9927	4467	2451	439	26,855	
Incident diabetes (%)	1,493 (15.6)	1,374 (13.8)	603 (13.5)	372 (15.2)	58 (13.2)	3,900 (14.5)	
FPG < 100 mg/dL, n	29,034	29,001	12,548	5944	1123	77,650	
Incident diabetes (%)	823 (2.8)	744 (2.6)	314 (2.5)	200 (3.4)	43 (3.8)	2,124 (2.7)	
FPG ≥ 100 mg/dL, n	7058	8910	5655	3016	513	25,152	
Incident diabetes (%)	1667 (23.6)	1850 (20.8)	1,100 (19.5)	661 (21.9)	108 (21.1)	5,386 (21.4)	
Male, n	22,517	30,441	16,544	8432	1,530	79,464	
Incident diabetes (%)	2,053 (9.1)	2431 (8.0)	1379 (8.3)	851 (10.1)	147 (9.6)	6,861 (8.6)	
Female, n	13,575	7470	1659	528	106	23,338	
Incident diabetes (%)	437 (3.3)	163 (2.2)	35 (2.1)	10 (1.9)	4 (3.8)	649 (2.8)	
BMI body mass index, FPG fasting plasma glucose.

Table 3 Adjusted hazard ratios for incidence of type 2 diabetes during follow-up period in whole participants.

	HR (95% CI)	
Age (per 1 years)	1.07 (1.07–1.08)	
Sex (ref: female)	1.64 (1.51–1.79)	
Body mass index (per 1 kg/m2)	1.20 (1.19–1.20)	
Smoking (past) (ref: none)	1.09 (1.02–1.17)	
Smoking (current) (ref: none)	1.44 (1.37–1.51)	
Alcohol consumption (ref: 0 g/day)	1	
0 < to < 22 g/day	0.85 (0.81–0.90)	
22 to < 39 g/day	0.92 (0.86–0.99)	
39 to < 66 g/day	0.99 (0.83–1.18)	
 ≥ 66 g/day	1.06 (0.90–1.25)	
Physical exercise (yes) (ref: no)	0.97 (0.91–1.03)	
Adjusted for age, sex, body mass index, smoking status, and exercise habits.

Fig. 2 Adjusted hazard ratios of alcohol consumption for incidence of type 2 diabetes according to BMI category adjusted for age, sex, smoking status, and exercise habits.

Supplementary Fig. 3 showed the sensitivity analysis examining the effects of BMI on the association between alcohol consumption levels and the incidence of type 2 diabetes after excluding incident cases that occurred within the first two years of the follow-up. The results were nearly equivalent to the results of the overall analysis. Supplementary Fig. 4 showed the sensitivity analysis examining the effects of BMI on the association between alcohol consumption levels and the incidence of type 2 diabetes after adding BMI as a continuous variable covariate. The results were nearly equivalent to the findings of the analysis without adding BMI as a continuous variable covariate. Supplementary Fig. 5 shows the sensitivity analysis according to BMI category of BMI < 23 kg/m2 and ≥ 23 kg/m2. The results were nearly equivalent to those of the BMI category of BMI < 25 kg/m2 and ≥ 25 kg/m2.

Discussion

The major findings of this study are that alcohol consumption at the level of 0 to < 22 g/day and 22 to < 39 g/day were negatively associated with developing type 2 diabetes in middle-aged Japanese. In participants with BMI < 25 kg/m2, alcohol consumption levels of 39 to < 66 g/day and ≥ 66 g/day were positively associated with developing type 2 diabetes. In the participants with BMI ≥ 25 kg/m2, alcohol consumption were negatively associated with developing type 2 diabetes. No interaction effects were found between alcohol consumption, and FPG category and sex on type 2 diabetes onset.

Although the mechanism through which alcohol consumption affects developing diabetes remains unknown, some studies have reported an association between alcohol consumption and insulin resistance. Alcohol consumption can improve insulin resistance27–30. Alcohol consumption increases insulin sensitivity by increasing adiponectin and leptin levels31,32. Previous studies showed that high levels of adiponectin are closely associated with increased insulin sensitivity33–35. A previous study demonstrated that low fasting plasma adiponectin levels are linked with reduced insulin-stimulated skeletal muscle insulin receptor tyrosine phosphorylation, which could be a potential cause of decreased insulin sensitivity36. Alcohol also has anti-inflammatory properties. A previous study found that alcohol consumption had a U-shaped association with C-reactive protein levels37. Furthermore, moderate ethanol consumption inhibits interleukin-6 production or activity38. Inflammation is also associated with insulin resistance39. Moreover, alcohol consumption may indirectly affect adipocytes because it has long been known that acetate, the chief circulating metabolite of alcohol, has an antilipolytic effect on adipocytes38,40. The ability of alcohol consumption to acutely lower free fat acid levels presumably reflects the generation of hepatic acetate41. Therefore, alcohol consumption may prevent insulin resistance by suppressing adipocyte lipolysis, resulting in reduced levels of circulating free fatty acids. On the other hand, alcohol consumption was associated with a significant decrease in the insulin secretion level at the alcohol consumption level of ≥ 40 g/day42. Excessive alcohol consumption can lead to pancreatic fibrosis43 and, depending on the amount, may potentially result in decreased insulin secretion due to alcohol intake.

In this study, different results were obtained after stratification according to BMI. In participants with BMI < 25 kg/m2, moderate-to-high alcohol consumption was positively associated with developing type 2 diabetes. In participants with BMI ≥ 25 kg/m2, alcohol consumption was negatively associated with developing type 2 diabetes. As mentioned earlier, alcohol consumption is associated with improving insulin resistance. Therefore, it might exert a negative association with the onset of diabetes in individuals with BMI ≥ 25 kg/m2, who are anticipated to have higher insulin resistance. Conversely, individuals with BMI < 25 kg/m2 who are not anticipated to have high insulin resistance may be less likely to benefit from this effect and may even face positive association with developing diabetes due to decreased insulin secretion caused by alcohol consumption. Previous reports have suggested that the impact of alcohol on type 2 diabetes may vary depending on the BMI in Japanese individuals44–47. Waki. et al.45 reported that moderate to high alcohol consumption was positively associated with developing type 2 diabetes in the participants with BMI ≤ 22 kg/m2, but not in the participants with BMI ≥ 22 kg/m2. Tsumura et al.46 reported that moderate to high alcohol consumption was negatively associated with developing type 2 diabetes in the participants with BMI ≥ 22 kg/m2, but not in the participants with BMI < 22 kg/m2. Watanabe et al.47 reported that alcohol consumption was positively associated with developing type 2 diabetes in individuals with BMI < 22 kg/m2, but not in those with BMI ≥ 25 kg/m2. In summary, alcohol consumption might have positive association with developing type 2 diabetes in individuals with a BMI ≤ 22 kg/m2, but may not have an impact on those with ≥ 25 kg/m2. However, previous reports had serious limitations, including small sample size, studies with short observation periods, no consideration of blood test data, and failure to consider the observation period in the analysis.

The present study included only Japanese people and showed results different from the association between alcohol consumption and the onset of type 2 diabetes in Western populations. There were several reasons for this observation. Even among obese individuals, the BMI of Japanese people tends to be lower than that of Western people. Therefore, the impact of alcohol consumption may differ between Japanese and Western populations. Ethanol, which is the main component of alcoholic beverages, decomposes into acetaldehyde. Aldehyde dehydrogenase 2 (ALDH2) is required for acetaldehyde decomposition. The ALDH2 allele appears to be most prevalent in Japanese, Chinese-American, Taiwanese, Han Chinese, Koreans, and many Japanese people who are unable to metabolize alcohol adequately compared to other racial groups, such as Western people48. Differences in ethanol metabolism might be involved in the variations in the effects of alcohol consumption on the onset of diabetes. Moreover, a unique Japanese food culture has evolved, comprising Japanese cuisine and sake. In particular, ethyl-α-D-glucoside, which is present in sake, has been found to prevent product of interleukin 6 and liver injury49. A previous study showed that the intake of sake lees extract improved insulin resistance via the improvement of hepatic inflammation in an animal model50. Therefore, alcohol consumption, including sake, might have negative association with the development of type 2 diabetes in the Japanese participants with BMI ≥ 25 kg/m2.

Previous report suggested that hypertension and dyslipidemia are implicated in the onset of type 2 diabetes51. However, in the current study, hypertension and dyslipidemia were not included as covariates. This decision was made because we believe that alcohol consumption may also impact blood pressure and lipid levels, suggesting that they could serve as intermediate factors in the onset of type 2 diabetes in our analyses.

The present study has certain limitations. First, it was an observational study. Consequently, not only unknown confounding factors but also measurement errors, especially self-reported alcohol consumption, may have existed. Second, the data on dietary intake were not considered. A previous study reported that significantly more food was consumed in the alcohol condition than in the no-alcohol condition52. Moreover, socioeconomic factors such as education and income levels, which could affect the development of type 2 diabetes, were not considered. Third, we were unable to sufficiently investigate the association with developing type 2 diabetes associated with alcohol consumption exceeding 66 g/day because any amount greater than 66 g/day is included in the category of ≥ 66 g/day based on the questionnaire format. Fourth, some types of alcohol contain additional bioactive components which may have affected the outcome. However, the type of alcohol the participants consumed was not recorded in this study. Additionally, we evaluated weight of alcohol consumed as a measure in this study. Other measures such as weight of alcohol as a ratio with weight of participant may have affected the outcome. Moreover, drinking habits are more prone to change over time. However, we used only baseline measurement of alcohol consumption. Fifth, previous report suggested that ALDH2 was associated with glucose metabolism in non-obese, non-diabetic Japanese53. Unfortunately, however, we have no data about the ALDH2. Sixth, we did not consider the competing risks, such as the incidence of other critical diseases, including cardiovascular and inflammatory diseases, in this study. Seventh, in this study, we evaluated the association between alcohol consumption levels and incidence of type 2 diabetes according to BMI category. However, BMI may not be the most accurate measure of adiposity, particularly in Asian populations. Finally, this study included only middle-aged Japanese employees. Therefore, it is unclear whether our results are applicable to other ethnic groups or populations.

This large-scale and long-term study identified that light alcohol consumption might have negative association with developing type 2 diabetes in middle-aged Japanese. Moderate-to-high alcohol consumption might have positive association with developing type 2 diabetes in Japanese with a BMI < 25 kg/m2. Alcohol consumption might have negative association with the development of type 2 diabetes in Japanese with BMI ≥ 25 kg/m2. However, there is evidence that alcohol consumption in any quantity has harmful effects54. We emphasize that the results of this study do not recommend alcohol consumption for the prevention of diabetes, and when consuming alcohol, responsible intake is recommended because alcohol consumption may induce alcoholic steatohepatitis, pancreatitis, cancers, dementia, cerebral hemorrhage, and mental disorders. Large prospective trials and more observational studies are needed to better assess the relationship between alcohol consumption and the development of type 2 diabetes in Japanese.

Methods

Study design

This long-term retrospective cohort study used data from 2008 to 2021 obtained from the Panasonic cohort study database, which included data on annual medical health checkups, medical costs, medical history, and mortality conducted by Panasonic Corporation, Osaka, Japan. All workers underwent annual medical health check-ups. The goal of this program is to improve public health by early detection of chronic illnesses, including metabolic disorders, and assessment of underlying risk factors.

Following a more than 10-h fast, blood samples were taken. The baseline attributes were evaluated using a standardized and validated self-administered questionnaire. Participants were categorized as nonsmokers, past smokers, or current smokers. Individuals were classified as smokers if they smoked at least one cigarette. Regular exercisers were defined as those who engaged in physical activity for at least 30 min, two days a week, for at least a year.

The Panasonic Health Insurance Organization's local ethics committee granted consent for this study (approval number: 2021–001), and it was carried out in conformity with the Declaration of Helsinki's principles. The data was anonymized. Informed consent was obtained using the opt-out method.

Alcohol consumption

Alcohol consumption was determined using a questionnaire that included the amount consumed per day and frequency per week. The survey assessed the frequency of alcohol consumption using the following questions: "Do not drink at all," "1–3 days a week," "4–6 days a week," and "Every day." Additionally, the daily alcohol intake was assessed with the following questions: "Less than 180 ml of sake," "180–360 ml of sake," "360–540 ml of sake," and "540 ml or more of sake." These formats are a common questionnaire format for alcohol consumption in health checkups in Japan, and the daily ethanol intake was calculated based on the average frequency and amount of alcohol consumed per day, where 180 ml of sake is considered equivalent to 22 g of ethanol. The amount of ethanol was estimated for a person consuming 270 ml of sake in a day and was calculated to be 33 g. “Beer 500 ml” and “wine 180 ml” were converted to the equivalent of “sake 180 ml” by participants using the self-administered questionnaire, thus calculating the ethanol content. Former drinkers were classified as non-drinkers. Alcohol consumption was categorized as 0 g/day, 0 < to < 22 g/day, 22 to < 39 g/day, 39 to < 66 g/day, and ≥ 66 g/day.

Inclusion and exclusion criteria

Figure 1 displays the study flow diagram for participant registration. Employees aged 40 and above who underwent medical health checkups between 2008 and 2020 were included in this study. We observed the onset of diabetes until 2021. Individuals who did not undergo a blood examination at baseline, those with missing data (BMI, self-administered questionnaires, or alcohol consumption), those with only baseline data, and those with diabetes at baseline were excluded from the study.

Definition of type 2 diabetes

A fasting plasma glucose (FPG) ≥ 126 mg/dL or being on diabetic therapy was considered as type 2 diabetes55. FPG was evaluated at every annual medical health check-up. The diabetic therapy was measured using a self-administered questionnaire. Type 2 diabetes incidence was measured between 2009 and 2021.

Covariates

The covariates were determined based on a directed acyclic graph from factors previously reported to be associated with the onset of diabetes51. Although previous study has reported that factors such as elevated blood pressure and dyslipidemia are also associated with the development of diabetes51, in this study, we treated them as intermediate factors.

Statistical analyses

Potential confounding variables were computed to determine their means and frequencies. The incidence of type 2 diabetes was calculated according to alcohol consumption. Cox regression analysis with multivariable models for interval-censored data was used to assess the relationship between alcohol consumption and the onset of type 2 diabetes. The cox.zph test was used to verify the proportional hazards assumption. Alcohol consumption was divided into five groups based on the baseline self-administered questionnaire: 0 g/day, 0 < to < 22 g/day, 22 to 39 < g/day, 39 to < 66 g/day, and ≥ 66 g/day. HRs were determined using a reference level of 0 g/day of alcohol consumption. The multivariable model was adjusted for BMI, sex, age, smoking status, and exercise habits. Subgroup analyses were performed to assess the effects of baseline BMI, FPG levels, and sex. Because the Japan Society for the Study of Obesity defines obesity as a BMI of ≥ 25 kg/m2 and elevated FPG was defined as FPG of ≥ 100 mg/dl55, the incidence of type 2 diabetes was stratified according to the categories of BMI < 25 kg/m2 and BMI ≥ 25 kg/m2, and FPG < 100 mg/dl and FPG ≥ 100 mg/dl at baseline. Moreover, we also assessed the effects of sex because there are differences in alcohol consumption between sexes. We also tested a potential interaction effect between BMI, FPG categories at baseline and sex, and alcohol consumption by including interaction terms in the Cox proportional hazards model. Considering reverse causation, we concluded sensitivity analysis after excluding incident cases that occurred within the first two years of the follow-up. Moreover, we also conducted a sensitivity analysis, adding BMI as a continuous variable covariate. Additionally, we conducted sensitivity analysis according to BMI category of BMI < 23 kg/m2 and ≥ 23 kg/m2.

The continuous variables are displayed either as absolute numbers or as mean ± SD. Differences were considered statistically significant at P < 0.05. Associations are presented as HRs with a 95% confidence interval (95% CI). Statistical analyses were performed using the JMP software version 17 (SAS Institute, Cary, NC, USA).

Supplementary Information

Supplementary Figure 1.

Supplementary Figure 2.

Supplementary Figure 3.

Supplementary Figure 4.

Supplementary Figure 5.

Supplementary Legends.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-024-71383-6.

Author contributions

F.T. wrote the manuscript. Y.H., H.M., and K.K. contributed to discussion. M.I. and H.O. contributed to conception and discussion and researched the data. M.F. and H.O. edited and reviewed the manuscript.

Data availability

If there are legitimate reasons, data will be provided through the corresponding author.

Competing interests

Fukui M received grants from Astellas Pharma Inc., Oishi Kenko inc., Abbott Japan Co. Ltd., Daiichi Sankyo Co. Ltd., Eli Lilly, Japan, K.K., Taisho Pharma Co., Ltd., MSD K.K., Nippon Boehringer Ingelheim Co. Ltd., Sanwa Kagagu Kenkyusho CO., Ltd., Nippon Chemiphar Co., Ltd., Ono Pharma Co. Ltd., Kissei Pharma Co. Ltd., Takeda Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corp., Novo Nordisk Pharma Ltd., Kyowa Kirin Co., Ltd., Sanofi K.K., Kowa Pharma Co. Ltd., Sumitomo Dainippon Pharma Co., Ltd., Tejin Pharma Ltd., Yamada Bee Farm, and Johnson & Johnson K.K. Medical Co., and TERUMO CORPORATION. Takahashi F, Okada H, Hashimoto Y, Kurogi K, Murata H, and Ito M had no conflicts of interest to declare.

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Sun H IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 Diabetes Res. Clin. Pract. 2022 183 109119 10.1016/j.diabres.2021.109119 34879977
Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).34879977 10.1016/j.diabres.2021.109119
2. Shah AD Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1·9 million people Lancet Diabetes Endocrinol. 2015 3 105 113 10.1016/S2213-8587(14)70219-0 25466521
Shah, A. D. et al. Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 3, 105–113 (2015).25466521 10.1016/S2213-8587(14)70219-0
3. Anagnostis P Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis Calcif. Tissue Int. 2020 107 453 463 10.1007/s00223-020-00742-y 32772138
Anagnostis, P. et al. Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis. Calcif. Tissue Int. 107, 453–463 (2020).32772138 10.1007/s00223-020-00742-y
4. Kosaka K Noda M Kuzuya T Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males Diabetes Res. Clin. Pract. 2005 67 152 162 10.1016/j.diabres.2004.06.010 15649575
Kosaka, K., Noda, M. & Kuzuya, T. Prevention of type 2 diabetes by lifestyle intervention: A Japanese trial in IGT males. Diabetes Res. Clin. Pract. 67, 152–162 (2005).15649575 10.1016/j.diabres.2004.06.010
5. Grøntved A Muscle-strengthening and conditioning activities and risk of type 2 diabetes: A prospective study in two cohorts of US women PLoS Med. 2014 11 e1001587 10.1371/journal.pmed.1001587 24453948
Grøntved, A. et al. Muscle-strengthening and conditioning activities and risk of type 2 diabetes: A prospective study in two cohorts of US women. PLoS Med. 11, e1001587 (2014).24453948 10.1371/journal.pmed.1001587
6. Saito T Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial Arch. Intern. Med. 2011 171 1352 1360 10.1001/archinternmed.2011.275 21824948
Saito, T. et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch. Intern. Med. 171, 1352–1360 (2011).21824948 10.1001/archinternmed.2011.275
7. Schrieks IC Heil ALJ Hendriks HFJ Mukamal KJ Beulens JWJ The effect of alcohol consumption on insulin sensitivity and glycemic status: A systematic review and meta-analysis of intervention studies Diabetes Care 2015 38 723 732 10.2337/dc14-1556 25805864
Schrieks, I. C., Heil, A. L. J., Hendriks, H. F. J., Mukamal, K. J. & Beulens, J. W. J. The effect of alcohol consumption on insulin sensitivity and glycemic status: A systematic review and meta-analysis of intervention studies. Diabetes Care 38, 723–732 (2015).25805864 10.2337/dc14-1556
8. Li XH Yu FF Zhou YH He J Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis Am J Clin Nutr 2016 103 818 829 10.3945/ajcn.115.114389 26843157
Li, X. H., Yu, F. F., Zhou, Y. H. & He, J. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am J Clin Nutr 103, 818–829 (2016).26843157 10.3945/ajcn.115.114389
9. Baliunas DO Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis Diabetes Care 2009 32 2123 2132 10.2337/dc09-0227 19875607
Baliunas, D. O. et al. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 32, 2123–2132 (2009).19875607 10.2337/dc09-0227
10. Koppes LLJ Dekker JM Hendriks HFJ Bouter LM Heine RJ Moderate alcohol consumption lowers the risk of type 2 diabetes: A meta-analysis of prospective observational studies Diabetes Care 2005 28 719 725 10.2337/diacare.28.3.719 15735217
Koppes, L. L. J., Dekker, J. M., Hendriks, H. F. J., Bouter, L. M. & Heine, R. J. Moderate alcohol consumption lowers the risk of type 2 diabetes: A meta-analysis of prospective observational studies. Diabetes Care 28, 719–725 (2005).15735217 10.2337/diacare.28.3.719
11. Knott C Bell S Britton A Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies Diabetes Care 2015 38 1804 1812 10.2337/dc15-0710 26294775
Knott, C., Bell, S. & Britton, A. Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. Diabetes Care 38, 1804–1812 (2015).26294775 10.2337/dc15-0710
12. Llamosas-Falcón L The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis Diabetes Care 2023 46 2076 2083 10.2337/dc23-1015 37890103
Llamosas-Falcón, L. et al. The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis. Diabetes Care 46, 2076–2083 (2023).37890103 10.2337/dc23-1015
13. Neuenschwander M Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies BMJ 2019 10.1136/bmj.l2368 31270064
Neuenschwander, M. et al. Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ10.1136/bmj.l2368 (2019).31270064 10.1136/bmj.l2368
14. Han M The Dose-Response Relationship between Alcohol Consumption and the Risk of Type 2 Diabetes among Asian Men: A Systematic Review and Meta-Analysis of Prospective Cohort Studies J. Diabetes Res. 2020 10.1155/2020/1032049 32908932
Han, M. The Dose-Response Relationship between Alcohol Consumption and the Risk of Type 2 Diabetes among Asian Men: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. J. Diabetes Res.10.1155/2020/1032049 (2020).32908932 10.1155/2020/1032049
15. Heianza Y Role of alcohol drinking pattern in type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 11 (TOPICS 11) Am. J. Clin. Nutr. 2013 97 561 568 10.3945/ajcn.112.043364 23343972
Heianza, Y. et al. Role of alcohol drinking pattern in type 2 diabetes in Japanese men: the Toranomon Hospital Health Management Center Study 11 (TOPICS 11). Am. J. Clin. Nutr. 97, 561–568 (2013).23343972 10.3945/ajcn.112.043364
16. Sawada SS Lee IM Muto T Matuszaki K Blair SN Cardiorespiratory fitness and the incidence of type 2 diabetes: prospective study of Japanese men Diabetes Care 2003 26 2918 2922 10.2337/diacare.26.10.2918 14514602
Sawada, S. S., Lee, I. M., Muto, T., Matuszaki, K. & Blair, S. N. Cardiorespiratory fitness and the incidence of type 2 diabetes: prospective study of Japanese men. Diabetes Care 26, 2918–2922 (2003).14514602 10.2337/diacare.26.10.2918
17. Roh WG Shin HC Choi JH Lee YJ Kim K Alcohol consumption and higher incidence of impaired fasting glucose or type 2 diabetes in obese Korean men Alcohol 2009 43 643 648 10.1016/j.alcohol.2009.10.005 20004342
Roh, W. G., Shin, H. C., Choi, J. H., Lee, Y. J. & Kim, K. Alcohol consumption and higher incidence of impaired fasting glucose or type 2 diabetes in obese Korean men. Alcohol 43, 643–648 (2009).20004342 10.1016/j.alcohol.2009.10.005
18. Han T Eighteen-year alcohol consumption trajectories and their association with risk of type 2 diabetes and its related factors: The China Health and Nutrition Survey Diabetologia 2019 62 970 10.1007/s00125-019-4851-z 30923839
Han, T. et al. Eighteen-year alcohol consumption trajectories and their association with risk of type 2 diabetes and its related factors: The China Health and Nutrition Survey. Diabetologia 62, 970 (2019).30923839 10.1007/s00125-019-4851-z
19. Li MJ Association of alcohol drinking with incident type 2 diabetes and pre-diabetes: The Guangzhou Biobank Cohort Study Diabetes Metab. Res. Rev. 2022 10.1002/dmrr.3548 36565185
Li, M. J. et al. Association of alcohol drinking with incident type 2 diabetes and pre-diabetes: The Guangzhou Biobank Cohort Study. Diabetes Metab. Res. Rev.10.1002/dmrr.3548 (2022).36565185 10.1002/dmrr.3548
20. Sato KK Relationship between drinking patterns and the risk of type 2 diabetes: The Kansai Healthcare Study J. Epidemiol. Commun. Health 2012 1978 66 507 511 10.1136/jech.2010.109777
Sato, K. K. et al. Relationship between drinking patterns and the risk of type 2 diabetes: The Kansai Healthcare Study. J. Epidemiol. Commun. Health 1978(66), 507–511 (2012).10.1136/jech.2010.109777
21. Teratani T Dose-response relationship between tobacco or alcohol consumption and the development of diabetes mellitus in Japanese male workers Drug Alcohol Depend. 2012 125 276 282 10.1016/j.drugalcdep.2012.03.002 22445622
Teratani, T. et al. Dose-response relationship between tobacco or alcohol consumption and the development of diabetes mellitus in Japanese male workers. Drug Alcohol Depend. 125, 276–282 (2012).22445622 10.1016/j.drugalcdep.2012.03.002
22. Shi L Physical activity, smoking, and alcohol consumption in association with incidence of type 2 diabetes among middle-aged and elderly Chinese men PLoS One 2013 8 e77919 10.1371/journal.pone.0077919 24223743
Shi, L. et al. Physical activity, smoking, and alcohol consumption in association with incidence of type 2 diabetes among middle-aged and elderly Chinese men. PLoS One 8, e77919 (2013).24223743 10.1371/journal.pone.0077919
23. Kawakami N Takatsuka N Shimizu H Ishibashi H Effects of smoking on the incidence of non-insulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees Am. J. Epidemiol. 1997 145 103 109 10.1093/oxfordjournals.aje.a009080 9006306
Kawakami, N., Takatsuka, N., Shimizu, H. & Ishibashi, H. Effects of smoking on the incidence of non-insulin-dependent diabetes mellitus. Replication and extension in a Japanese cohort of male employees. Am. J. Epidemiol. 145, 103–109 (1997).9006306 10.1093/oxfordjournals.aje.a009080
24. Nakanishi N Suzuki K Tatara K Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men Diabetes Care 2003 26 48 54 10.2337/diacare.26.1.48 12502657
Nakanishi, N., Suzuki, K. & Tatara, K. Alcohol consumption and risk for development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. Diabetes Care 26, 48–54 (2003).12502657 10.2337/diacare.26.1.48
25. Jee SH Foong AW Hur NW Samet JM Smoking and risk for diabetes incidence and mortality in Korean men and women Diabetes Care 2010 33 2567 2572 10.2337/dc10-0261 20823342
Jee, S. H., Foong, A. W., Hur, N. W. & Samet, J. M. Smoking and risk for diabetes incidence and mortality in Korean men and women. Diabetes Care 33, 2567–2572 (2010).20823342 10.2337/dc10-0261
26. Yabe D Seino Y Fukushima M Seino S β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians Curr. Diab. Rep. 2015 10.1007/s11892-015-0602-9 25944304
Yabe, D., Seino, Y., Fukushima, M. & Seino, S. β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr. Diab. Rep.10.1007/s11892-015-0602-9 (2015).25944304 10.1007/s11892-015-0602-9
27. Flanagan DEH Alcohol consumption and insulin resistance in young adults Eur. J. Clin. Invest. 2000 30 297 301 10.1046/j.1365-2362.2000.00624.x 10759877
Flanagan, D. E. H. et al. Alcohol consumption and insulin resistance in young adults. Eur. J. Clin. Invest. 30, 297–301 (2000).10759877 10.1046/j.1365-2362.2000.00624.x
28. Mayer EJ Newman B Quesenberry CP Friedman GD Selby JV Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides Circulation 1993 88 2190 2197 10.1161/01.CIR.88.5.2190 8222114
Mayer, E. J., Newman, B., Quesenberry, C. P., Friedman, G. D. & Selby, J. V. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 88, 2190–2197 (1993).8222114 10.1161/01.CIR.88.5.2190
29. Facchini F Chen YDI Reaven GM Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity Diabetes Care 1994 17 115 119 10.2337/diacare.17.2.115 7907975
Facchini, F., Chen, Y. D. I. & Reaven, G. M. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17, 115–119 (1994).7907975 10.2337/diacare.17.2.115
30. Kiechl S Insulin sensitivity and regular alcohol consumption: Large, prospective, cross sectional population study (Bruneck study) BMJ 1996 313 1040 1044 10.1136/bmj.313.7064.1040 8898593
Kiechl, S. et al. Insulin sensitivity and regular alcohol consumption: Large, prospective, cross sectional population study (Bruneck study). BMJ 313, 1040–1044 (1996).8898593 10.1136/bmj.313.7064.1040
31. Ábel T Fehér J Effect of moderate alcohol consumption on insulin sensitivity Orv. Hetil. 2009 150 2218 2221 10.1556/oh.2009.28750 19939782
Ábel, T. & Fehér, J. Effect of moderate alcohol consumption on insulin sensitivity. Orv. Hetil. 150, 2218–2221 (2009).19939782 10.1556/oh.2009.28750
32. Paulson QX Hong J Holcomb VB Nunez NP Effects of body weight and alcohol consumption on insulin sensitivity Nutr. J. 2010 10.1186/1475-2891-9-14 20307313
Paulson, Q. X., Hong, J., Holcomb, V. B. & Nunez, N. P. Effects of body weight and alcohol consumption on insulin sensitivity. Nutr. J.10.1186/1475-2891-9-14 (2010).20307313 10.1186/1475-2891-9-14
33. Weyer C Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J. Clin. Endocrinol. Metab. 2001 86 1930 1935 10.1210/jcem.86.5.7463 11344187
Weyer, C. et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930–1935 (2001).11344187 10.1210/jcem.86.5.7463
34. Hotta K Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys Diabetes 2001 50 1126 1133 10.2337/diabetes.50.5.1126 11334417
Hotta, K. et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126–1133 (2001).11334417 10.2337/diabetes.50.5.1126
35. Cnop M Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 2003 46 459 469 10.1007/s00125-003-1074-z 12687327
Cnop, M. et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46, 459–469 (2003).12687327 10.1007/s00125-003-1074-z
36. Stefan N Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans Diabetes 2002 51 1884 1888 10.2337/diabetes.51.6.1884 12031977
Stefan, N. et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51, 1884–1888 (2002).12031977 10.2337/diabetes.51.6.1884
37. Imhof A Effect of alcohol consumption on systemic markers of inflammation Lancet 2001 357 763 767 10.1016/S0140-6736(00)04170-2 11253971
Imhof, A. et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 357, 763–767 (2001).11253971 10.1016/S0140-6736(00)04170-2
38. McCarty MF Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline Med. Hypotheses 1999 52 465 477 10.1054/mehy.1997.0684 10416955
McCarty, M. F. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med. Hypotheses 52, 465–477 (1999).10416955 10.1054/mehy.1997.0684
39. Shoelson SE Lee J Goldfine AB Inflammation and insulin resistance J. Clin. Invest. 2006 116 1793 1801 10.1172/JCI29069 16823477
Shoelson, S. E., Lee, J. & Goldfine, A. B. Inflammation and insulin resistance. J. Clin. Invest. 116, 1793–1801 (2006).16823477 10.1172/JCI29069
40. Larsen TS Nilsson NÖ Blix AS Effects of volatile fatty acids and ketone bodies on lipolysis in isolated adipocytes from Norwegian reindeer (Rangifer tarandus) Acta Physiol. Scand. 1983 117 451 455 10.1111/j.1748-1716.1983.tb00020.x 6880805
Larsen, T. S., Nilsson, N. Ö. & Blix, A. S. Effects of volatile fatty acids and ketone bodies on lipolysis in isolated adipocytes from Norwegian reindeer (Rangifer tarandus). Acta Physiol. Scand. 117, 451–455 (1983).6880805 10.1111/j.1748-1716.1983.tb00020.x
41. Israelsen M Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication JHEP Rep. 2021 3 100325 10.1016/j.jhepr.2021.100325 34401690
Israelsen, M. et al. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. JHEP Rep. 3, 100325 (2021).34401690 10.1016/j.jhepr.2021.100325
42. Ueda N Alcohol-induced impaired insulin secretion in a Japanese population: 5-year follow up in the Gifu Diabetes Study J. Diabetes Investig. 2020 11 1207 1214 10.1111/jdi.13260 32227447
Ueda, N. et al. Alcohol-induced impaired insulin secretion in a Japanese population: 5-year follow up in the Gifu Diabetes Study. J. Diabetes Investig. 11, 1207–1214 (2020).32227447 10.1111/jdi.13260
43. Zorniak M Sirtl S Mayerle J Beyer G What do we currently know about the pathophysiology of alcoholic pancreatitis: A brief review Visc. Med. 2020 36 182 190 10.1159/000508173 32775348
Zorniak, M., Sirtl, S., Mayerle, J. & Beyer, G. What do we currently know about the pathophysiology of alcoholic pancreatitis: A brief review. Visc. Med. 36, 182–190 (2020).32775348 10.1159/000508173
44. Seike N, Noda M & Kadowaki T. Alcohol consumption and risk of type 2 diabetes mellitus in Japanese: a systematic review - PubMed. Asia Pac J Clin Nutr 545–551 https://pubmed.ncbi.nlm.nih.gov/19114388/ (2008).
45. Waki K Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I Diabet Med. 2005 22 323 331 10.1111/j.1464-5491.2004.01403.x 15717882
Waki, K. et al. Alcohol consumption and other risk factors for self-reported diabetes among middle-aged Japanese: a population-based prospective study in the JPHC study cohort I. Diabet Med. 22, 323–331 (2005).15717882 10.1111/j.1464-5491.2004.01403.x
46. Tsumura K Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey Diabetes Care 1999 22 1432 1437 10.2337/diacare.22.9.1432 10480505
Tsumura, K. et al. Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka Health Survey. Diabetes Care 22, 1432–1437 (1999).10480505 10.2337/diacare.22.9.1432
47. Watanabe M Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese Diabetes Res. Clin. Pract. 2002 57 191 197 10.1016/S0168-8227(02)00083-9 12126769
Watanabe, M. et al. Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese. Diabetes Res. Clin. Pract. 57, 191–197 (2002).12126769 10.1016/S0168-8227(02)00083-9
48. Eng, M. Y., Luczak, S. E. & Wall, T. L. ALDH2, ADH1B, AND ADH1C GENOTYPES IN ASIANS: A LITERATURE REVIEW.
49. Izu H Hizume K Goto K Hirotsune M Hepatoprotective effects of a concentrate and components of sake against galactosamine (GalN)-induced liver injury in mice Biosci. Biotechnol. Biochem. 2007 71 951 957 10.1271/bbb.60613 17420605
Izu, H., Hizume, K., Goto, K. & Hirotsune, M. Hepatoprotective effects of a concentrate and components of sake against galactosamine (GalN)-induced liver injury in mice. Biosci. Biotechnol. Biochem. 71, 951–957 (2007).17420605 10.1271/bbb.60613
50. Kubo H Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice Lipids Health Dis. 2017 10.1186/s12944-017-0501-y 28578672
Kubo, H. et al. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. Lipids Health Dis.10.1186/s12944-017-0501-y (2017).28578672 10.1186/s12944-017-0501-y
51. Saijo Y The Risk Factors for Development of Type 2 Diabetes: Panasonic Cohort Study 4 Int. J. Environ. Res. Public Health 2022 19 571 10.3390/ijerph19010571 35010830
Saijo, Y. et al. The Risk Factors for Development of Type 2 Diabetes: Panasonic Cohort Study 4. Int. J. Environ. Res. Public Health 19, 571 (2022).35010830 10.3390/ijerph19010571
52. Yeomans MR Alcohol, appetite and energy balance: Is alcohol intake a risk factor for obesity? Physiol. Behav. 2010 100 82 89 10.1016/j.physbeh.2010.01.012 20096714
Yeomans, M. R. Alcohol, appetite and energy balance: Is alcohol intake a risk factor for obesity?. Physiol. Behav. 100, 82–89 (2010).20096714 10.1016/j.physbeh.2010.01.012
53. Takeno K ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men J. Clin. Endocrinol. Metab. 2021 106 3573 3581 10.1210/clinem/dgab324
Takeno, K. et al. ALDH2 rs671 Is Associated With Elevated FPG, Reduced Glucose Clearance and Hepatic Insulin Resistance in Japanese Men. J. Clin. Endocrinol. Metab. 106, 3573–3581 (2021).10.1210/clinem/dgab324
54. Griswold MG Alcohol use and burden for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016 Lancet 2018 392 1015 1035 10.1016/S0140-6736(18)31310-2 30146330
Griswold, M. G. et al. Alcohol use and burden for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 392, 1015–1035 (2018).30146330 10.1016/S0140-6736(18)31310-2
55. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care 47(Suppl 1), S20–S42 (2024).
